This Exemption ends on: (a) 30 April 2017; or (b) the date when the Goods are entered on the Australian Register of Therapeutic Goods with an indication commensurate with the treatment of viral haemorrhagic fevers including Lassa Fever, Crimean-Congo Haemorrhagic fever and Hantavirus infection, whichever occurs first in relation to the Goods.
Australian Government
This Exemption ends on: (a) 30 April 2017; or (b) the date when the Goods are entered on the Australian Register of Therapeutic Goods with an indication commensurate with the treatment of viral haemorrhagic fevers including Lassa Fever, Crimean-Congo Haemorrhagic fever and Hantavirus infection, whichever occurs first in relation to the Goods.